DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 19:03:33 07/06/2024 BST | ||
| 171.7 EUR | +0.56% |
|
| Current month | +0.92% | ||
| 1 month | +0.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 171.7 | +0.56% |
| 06/06/24 | 170.7 | -0.05% |
| 05/06/24 | 170.8 | +0.38% |
| 04/06/24 | 170.2 | +0.14% |
| 03/06/24 | 169.9 | -0.11% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 07:03 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5USH |
| ISIN | DE000VM5USH2 |
| Date issued | 22/11/2023 |
| Maturity | 20/09/2024 (103 Days) |
| Parity | 1 : 1 |
| Emission price | 163.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 171.7 € |
|---|---|
| Lowest since issue | 159.2 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.4
USD
Average target price
284.6
USD
Spread / Average Target
+26.26%
- Stock Market
- Certificates
- Certificat